SomnoMed Limited (ASX:SOM)
Australia · Delayed Price · Currency is AUD 0.8250
+0.0400 (5.10%)
Aug 7, 2025, 4:10 PM AEST
DFS Market Cap
SomnoMed has a market cap or net worth of 169.64 million as of August 7, 2025. Its market cap has increased by 196.23% in one year.
Market Cap
169.64M
Enterprise Value
157.06M
Revenue
100.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.83
Market Cap Chart
Since August 27, 2004, SomnoMed's market cap has increased from 35.20M to 169.64M, an increase of 381.90%. That is a compound annual growth rate of 7.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 169.64M | 70.65% |
| Dec 27, 2024 | 99.41M | 83.09% |
| Dec 29, 2023 | 54.30M | -49.14% |
| Dec 28, 2022 | 106.76M | -45.11% |
| Dec 31, 2021 | 194.48M | 11.90% |
| Dec 31, 2020 | 173.79M | -5.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 128.57B |
| Pro Medicus | 33.41B |
| Cochlear | 20.50B |
| Sonic Healthcare | 13.76B |
| Ramsay Health Care | 8.81B |
| Telix Pharmaceuticals | 6.16B |
| Ansell | 4.47B |
| Mesoblast | 3.02B |